(July 24, 2020, 1:24 PM EDT) -- PHILADELPHIA — Taro Pharmaceuticals U.S.A. Inc. entered into a deferred prosecution agreement (DPA) admitting to engaging in antitrust activities and agreeing to pay a $205.65 million criminal penalty, the U.S. Justice Department said in a July 23 press release....